Why It Matters
The Coalition for a Prosperous America Education Fund Inc. is lobbying on the PILLS Act, which would establish production-based and investment tax credits for generic medicines. Both the House and Senate versions are listed as introduced and referred to committee, with no related hearings identified in the cited legislative records. The legislation would create production tax credits of 30% to 35% and a 25% investment tax credit for U.S. manufacturers of generic drugs and biosimilars, aiming to encourage domestic production.
By the Numbers
The organization's third-quarter disclosure, an in-house report signed Oct. 20, lists $300,000 in lobbying expenditures. That figure is unchanged from the second quarter and the third quarter of 2025.
The filing names two lobbyists, down from four in the previous quarter:
- E.J. Valentine Jr., government relations director, with prior congressional staff experience in the offices of Sen. Rick Scott (R-FL), Rep. Carlos Giménez (R-FL) and former Rep. Jeb Hensarling (R-TX).
- Jim Stuber, legislative counsel, with prior government experience noted in his record.
Broader Context
PILLS Act
Rep. Claudia Tenney (R-NY) introduced H.R. 1396 on Feb. 14, 2025. The House referred the bill to the Ways and Means Committee. S. 1891 was introduced on May 22, 2025, and referred to the Senate Finance Committee. Reps. Nicole Malliotakis (R-NY) and Greg Steube (R-FL) are listed as cosponsors of the House bill.
Section 232 tariffs
A June 2025 presidential proclamation raised Section 232 tariffs on steel and aluminum imports to 50%. An April proclamation subsequently modified the tariff regimes for steel, aluminum, and copper, establishing a 50% rate for covered metal articles and certain derivatives, with lower rates for specified products. A June 1 proclamation further adjusted those tariffs, including reduced rates for certain agricultural and industrial equipment and revised requirements for products incorporating U.S.-produced metals. The June changes generally took effect June 8.
The Coalition for a Prosperous America (CPA) has publicly endorsed maintaining Section 232 steel tariffs without exemptions, with CPA Senior Economist Mihir Torsekar arguing that the tariffs protect national security and citing 21 million metric tons of announced or completed new U.S. steel capacity since 2018.
COOL Online Act
The Senate and House versions of the Country of Origin Labeling Requirement Act, or COOL Online Act, would require online sellers of imported products to conspicuously disclose the country of origin and the seller's principal place of business, with enforcement by the Federal Trade Commission (FTC). Sen. Tammy Baldwin (D-WI) introduced the COOL Online Act (S. 294) on Jan. 29, 2025.
Competitive Landscape
The Electronic Frontier Foundation and the Association for Accessible Medicines are associated with H.R. 1396 in the cited legislative records. The Computer and Communications Industry Association is associated with H.R. 9057. The information provided does not establish the nature of those associations, including whether the organizations support or oppose the legislation.
The Bottom Line
Both versions of the PILLS Act are listed as introduced and referred to committee: H.R. 1396 to the House Ways and Means Committee and S. 1891 to the Senate Finance Committee. According to the cited legislative accounts, the COOL Online Act also awaits committee action in both chambers. The organization's lobbying team shrank from four to two lobbyists between the second and third quarters, while its reported quarterly spending stayed at $300,000.
Access the Legis1 platform for comprehensive political news, data, and insights
Spot something wrong? Report an issue with this article
